Sign in

Filings

Finds words inside filing documents. Searching BRISTOL MYERS SQUIBB CO's filings · 35 documents indexed.

19 documents · 29 matches

  1. BMY BRISTOL MYERS SQUIBB CO 10-K 2026-02-11

    Item 1A. Risk Factors.

    tariffs on our business and results of operations, and it is possible that such tariffs, or future tariffs, may result
    6 matches in this document

  2. BMY BRISTOL MYERS SQUIBB CO 10-Q 2025-10-30

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs. While pharmaceuticals are largely exempt from the recently imposed U.S. tariffs, such exemptions may be terminated or may not apply
    2 matches in this document

  3. BMY BRISTOL MYERS SQUIBB CO 10-Q 2025-07-31

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariffs. While pharmaceuticals are largely exempt from the recently imposed U.S. tariffs, such exemptions may be terminated or may not apply
    2 matches in this document

  4. BMY BRISTOL MYERS SQUIBB CO 10-Q 2026-10-29

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff relief until January 2029, including for recently imposed tariffs relating to patented pharmaceuticals and associated pharmaceutical ingredients pursuant to the Presidential
    2 matches in this document

  5. BMY BRISTOL MYERS SQUIBB CO 10-Q 2026-07-30

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff relief until January 2029, including for recently imposed tariffs relating to patented pharmaceuticals and associated pharmaceutical ingredients pursuant to the Presidential
    2 matches in this document

  6. BMY BRISTOL MYERS SQUIBB CO 10-Q 2026-04-30

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

    tariff relief until January 2029, including for recently imposed tariffs relating to patented pharmaceuticals and associated pharmaceutical ingredients pursuant to the Presidential
    2 matches in this document

  7. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-10-29

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  8. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-10-29

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most-favored nation drug pricing for our products
    1 match in this document

  9. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-07-30

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  10. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-07-30

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most-favored nation drug pricing for our products
    1 match in this document

  11. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-04-30

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  12. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-04-30

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most-favored nation drug pricing for our products
    1 match in this document

  13. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-02-05

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  14. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-02-05

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most-favored nation drug pricing for our products
    1 match in this document

  15. BMY BRISTOL MYERS SQUIBB CO 8-K 2026-01-12

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most-favored nation drug pricing for our products
    1 match in this document

  16. BMY BRISTOL MYERS SQUIBB CO 8-K 2025-10-30

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  17. BMY BRISTOL MYERS SQUIBB CO 8-K 2025-10-30

    tariffs, trade restrictions and export regulations, including the potential for international reference pricing and most- favored nation drug pricing for our products
    1 match in this document

  18. BMY BRISTOL MYERS SQUIBB CO 8-K 2025-07-31

    tariffs, trade restrictions and export regulations; the company’s ability to retain patent and market exclusivity for certain products; regulatory
    1 match in this document

  19. BMY BRISTOL MYERS SQUIBB CO 8-K 2025-07-31

    tariffs, trade restrictions and export regulations, (ii) our ability to obtain, protect and maintain market exclusivity rights and enforce patents
    1 match in this document

Page 1 of 1 · 19 documents